Ahmed Z Alanazi Selected Research

1-methyl-1H-indole-2-carboxylic acid (4- (1- (4- (4- acetylpiperazin- 1- yl)cyclohexyl)- 4- amino- 1H- pyrazolo(3,4- d)pyrimidin- 3- yl)- 2- methoxyphenyl)amide

1/2022

Lck signaling inhibition causes improvement in clinical features of psoriatic inflammation through reduction in inflammatory cytokines in CD4+ T cells in imiquimod mouse model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ahmed Z Alanazi Research Topics

Disease

5	Inflammation (Inflammations) 01/2022 - 01/2020
2	Wounds and Injuries (Trauma) 01/2020 - 01/2020
1	Metabolic Diseases (Metabolic Disease) 01/2022
1	Otitis 01/2022
1	Cardiotoxicity 09/2021
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2020
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2020
1	Dyslipidemias (Dyslipidemia) 01/2020
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2020
1	Liver Diseases (Liver Disease) 01/2020
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2020
1	Fibrosis (Cirrhosis) 01/2020
1	Hyperglycemia 01/2020
1	Autistic Disorder (Autism) 10/2019
1	Neuroinflammatory Diseases 10/2019
1	Multiple Myeloma 01/2019
1	Neoplasms (Cancer) 01/2019
1	Pneumonia (Pneumonitis) 01/2019
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2019
1	Acute Lung Injury 01/2019
1	Vascular System Injuries 01/2019

Drug/Important Bio-Agent (IBA)

3	CytokinesIBA 01/2022 - 10/2019
2	Valsartan (Vals)FDA Link 09/2021 - 01/2020
2	AntioxidantsIBA 01/2020 - 01/2020
2	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2020 - 01/2020
1	1-methyl-1H-indole-2-carboxylic acid (4- (1- (4- (4- acetylpiperazin- 1- yl)cyclohexyl)- 4- amino- 1H- pyrazolo(3,4- d)pyrimidin- 3- yl)- 2- methoxyphenyl)amideIBA 01/2022
1	p38 Mitogen-Activated Protein KinasesIBA 01/2022
1	Interleukin-17 (Interleukin 17)IBA 01/2022
1	Imiquimod (Aldara)FDA LinkGeneric 01/2022
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	Biological ProductsIBA 01/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2021
1	Ketamine FDA LinkGeneric 01/2020
1	perampanelIBA 01/2020
1	Blood Glucose (Blood Sugar)IBA 01/2020
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2020
1	Transaminases (Aminotransferases)IBA 01/2020
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2020
1	Streptozocin (Streptozotocin)FDA Link 01/2020
1	EnzymesIBA 01/2020
1	Hematoxylin (Haematoxylon)IBA 01/2020
1	Chemokine ReceptorsIBA 10/2019
1	Therapeutic UsesIBA 10/2019
1	NSC 74859IBA 10/2019
1	apremilastIBA 01/2019
1	Pharmaceutical PreparationsIBA 01/2019
1	Peroxidase (Myeloperoxidase)IBA 01/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019
1	carfilzomibIBA 01/2019
1	Proteasome InhibitorsIBA 01/2019

Therapy/Procedure

3	Therapeutics 01/2020 - 01/2019
2	Drug Therapy (Chemotherapy) 01/2020 - 01/2019